Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc. financial statements

Phathom Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 175.11M10-K
Net income−USD 221.25M10-K
Cash and equivalentsUSD 129.97M10-Q
Total debtUSD 209.09M10-Q

Phathom Pharmaceuticals, Inc. financials on 6ix · Phathom Pharmaceuticals, Inc. on 6ix